SCIENTIA ADVISORS: NEWS
Release Date: 02/29/2008BREAKFAST SERIES: PERSONALIZED MEDICINE
The rush to provide the $1000 genome, the development of pharmacogenomics, and the increasing challenges to the ‘blockbuster drug model’ have raised the emphasis on personalized medicine within the life science industry. Through the breakfast series, Scientia Advisors will explore the following topics:
Panelists will be:
Dr. Raju Kucherlapati
Scientific Director of Harvard Partners Center for Genetics and Genomics
Mara G. Aspinal
President of Genzyme Genetics
The breakfast series will take place on February 29th, 2008 from 7.30am to 9.00am at 1 Broadway, 5th floor, Cambridge, MA 02142.
Click here to download PDF version- What are the challenges faced when implementing the new paradigm of personalized medicine?
- What are pharmaceutical and biotechnology companies doing today to adapt and what future developments are on the horizon?
Panelists will be:
Dr. Raju Kucherlapati
Scientific Director of Harvard Partners Center for Genetics and Genomics
Mara G. Aspinal
President of Genzyme Genetics
The breakfast series will take place on February 29th, 2008 from 7.30am to 9.00am at 1 Broadway, 5th floor, Cambridge, MA 02142.
